agriculture · consumer_protection · food_and_nutrition · HHS-FDA
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Food and Drug Administration · FOR-FD-25-020
Deadline
TBD
GRANTQUICK SUMMARYPlain-English Overview
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required). Food and Drug Administration. The purpose of this opportunity is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of... Funding amounts not specified.
Who Should Apply
Other eligible entities
Who Should NOT Apply
Individuals and organizations outside the specified eligible types
Key Requirements (Plain English)
- •Higher Education Institutions Public/State Controlled Institutions of Higher Education Private Institutions of Higher Education Nonprofits Oth...
💡 GrantQuick Tip
Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.
Competitiveness: Moderate to high — federal grants are always competitive
What This Grant Funds
The purpose of this opportunity is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare diseases and exert a broad and positive impact on rare disease drug development.
Who Can Apply
Eligible Applicant Types
Funding Details
- Cost Sharing Required?
- No
- Funding Instrument
- grant
Key Dates
Agency Contact
Kimberly Pendleton 240-402-7610
Kimberly.Pendleton@fda.hhs.govReady to apply?
View the full NOFO and submit your application on Grants.gov